Anti-Saccharomyces cerevisiae antibodies in patients with COVID-19

BACKGROUND AND STUDY AIM: Anti-Saccharomyces cerevisiae antibodies (ASCA) have been described in many autoimmune diseases (AIDs). Coronavirus disease 2019 (COVID-19) could trigger AIDs. This study aimed to determine the frequency of ASCA in patients with COVID-19. PATIENTS AND METHODS: This study in...

Descripción completa

Detalles Bibliográficos
Autores principales: Melayah, Sarra, Mankaï, Amani, Jemni, Malek, Chaben, Arij Ben, Ghozzi, Mariam, Ben Abdelkrim, Asma, Ach, Kousay, Ghariani, Nadia, Denguezli, Mohamed, Benzarti, Wafa, Benzarti, Mohamed, Melayah, Salma, Naija, Walid, Ghedira, Ibtissem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309156/
https://www.ncbi.nlm.nih.gov/pubmed/36351870
http://dx.doi.org/10.1016/j.ajg.2022.07.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309156/
https://www.ncbi.nlm.nih.gov/pubmed/36351870
http://dx.doi.org/10.1016/j.ajg.2022.07.001

Ejemplares similares